Organon FY 2025: revenue $6.2B, down 3%; diluted EPS $0.72

Key figures from this report

These are the numbers Organon reported for the year ended Dec 31, 2025, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

1. Revenue$6.2B−3% from $6.4B in FY 202410-K income statement, on EDGAR
2. Net income$187.0M−78% from $864.0M in FY 202410-K income statement, on EDGAR
3. Diluted EPS$0.72−78% from $3.33 in FY 202410-K income statement, on EDGAR
4. Cash and cash equivalents$574.0M−15% from $675.0M in FY 202410-K balance sheet, on EDGAR
5. Cash from operations$700.0M−25% from $939.0M in FY 202410-K cash flow statement, on EDGAR

Every year in the financial tables